HAEVSSXTC• 12 Months (Normalized)
HAE vs SXTC (Haemonetics Corporation vs China SXT Pharmaceuticals Inc.)
Showing Closing Date Range from Oct 7, 2025 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HAE Performance $103.52
+110.15%
Haemonetics Corporation
Normalized Baseline0.00%
SXTC Performance $1.25
-99.99%
China SXT Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin HAE LEADS
+210.14 pts
HAE outperforming by 210.14 percentage points
HAESXTC
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HAE SXTC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(250 dates)
| Date | HAE Price | HAE Gain (%) | SXTC Price | SXTC Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $103.52 | +110.15% | $1.25 | -99.99% | +210.14% |
| Oct 05, 2026 | $104.68 | +112.51% | $2.08 | -99.99% | +212.50% |
| Oct 02, 2026 | $104.68 | +112.51% | $2.41 | -99.99% | +212.50% |
| Oct 01, 2026 | $104.37 | +111.88% | $2.96 | -99.98% | +211.86% |
| Sep 30, 2026 | $105.30 | +113.76% | $3.01 | -99.98% | +213.74% |
| Sep 29, 2026 | $105.80 | +114.78% | $2.81 | -99.99% | +214.77% |
| Sep 28, 2026 | $105.79 | +114.76% | $2.52 | -99.99% | +214.75% |
| Sep 25, 2026 | $105.30 | +113.76% | $- | - | |
| Sep 23, 2026 | $106.82 | +116.85% | $2.51 | -99.99% | +216.84% |
| Sep 22, 2026 | $108.52 | +120.30% | $- | - | |
| Sep 21, 2026 | $108.73 | +120.73% | $2.38 | -99.99% | +220.72% |
| Sep 18, 2026 | $108.40 | +120.06% | $2.40 | -99.99% | +220.05% |
| Sep 17, 2026 | $107.60 | +118.43% | $2.44 | -99.99% | +218.42% |
| Sep 16, 2026 | $106.24 | +115.67% | $2.19 | -99.99% | +215.66% |
| Sep 15, 2026 | $106.20 | +115.59% | $2.36 | -99.99% | +215.58% |
Page 1 of 17